NYSE-listed $2 billion Pall Corporation has opened its life sciences centre in Bangalore to cater to the Asian life sciences market. | |
| The company, without disclosing the investment made in the new facility, said the centre can house 60 scientists and assist the pharmaceutical, biotechnology and discovery markets in Asia with a range of total fluid management solutions. These involve liquids required in drug discovery and manufacturing. |
| |
| India was strategically chosen as the location for Pall's new centre in Asia due to India's size (total fluid solution market valued at $5 billion) and reputation in life sciences spanning bio-pharmaceutical research, development and production. |
| |
| The country's diverse market opportunities and a large pool of qualified scientists and engineers provide an ideal climate for fuelling innovation and growth, said Roberto Perez, President, Pall Life Sciences Worldwide. |
| |
| According to Vinay Joban, General Manager, Pall Biopharmaceuticals India, the fluid solution market in India is estimated to be around $5 billion in which process management and therapy segments constitute $2 billion each and the balance is accounted for by proteomics and separation. |
| |
